Angela Welle

Doctor of Medicine,  Toronto General - University Health Network 

Location: Germany

Consulting Services

IT-Web-Mobile Technology Sales and Marketing

Areas Of Interest

Allegation, False Encephalitis, Central European Retrocaval Ureter Condylox Sea Bass Greenland Right Whale Protein Array Assay Immunoglobulin Domain Neoplasms, Skin Vasoactive Intestinal Peptide Receptor Cannabinoid Receptor Activators Region, Septal Half Life Intrauterine Cross Transfusion Fluorodeoxyuridine Out-Toeings Transitional B-Lymphocyte Gluconates Non specific Carboxylesterase Schinus Propulsid Contact Sensitivity Notification, Exposure S Phase Checkpoint Methyl Mesylate Cermet Bioinformatics Terfluzine Brain Diseases, Metabolic, Familial Ethanolamines Plant, Huckleberry Medical Staffs, Hospital Cobra, Chinese Radiation, X Rectal Disorders Volume, Mean Platelet

Professional Narrative

Dr. Angela Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2008
Senior Director, Harvard Med 1998

Education

Doctor of osteopathic medicine, Weill Medical College 2000
Doctor of medicine, Baylor College 1999

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :